19-13207858-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTGCTGCTG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001127222.2(CACNA1A):c.6970_6975delCAGCAG(p.Gln2324_Gln2325del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.308 in 1,259,014 control chromosomes in the GnomAD database, including 36,422 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 12013 hom., cov: 0)
Exomes 𝑓: 0.31 ( 36422 hom. )
Failed GnomAD Quality Control
Consequence
CACNA1A
NM_001127222.2 conservative_inframe_deletion
NM_001127222.2 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 19-13207858-CCTGCTG-C is Benign according to our data. Variant chr19-13207858-CCTGCTG-C is described in ClinVar as [Likely_benign]. Clinvar id is 445458.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-13207858-CCTGCTG-C is described in Lovd as [Benign]. Variant chr19-13207858-CCTGCTG-C is described in Lovd as [Likely_benign]. Variant chr19-13207858-CCTGCTG-C is described in Lovd as [Benign].
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6970_6975delCAGCAG | p.Gln2324_Gln2325del | conservative_inframe_deletion | 47/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6988_6993delCAGCAG | p.Gln2330_Gln2331del | conservative_inframe_deletion | 48/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6976_6981delCAGCAG | p.Gln2326_Gln2327del | conservative_inframe_deletion | 47/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6973_6978delCAGCAG | p.Gln2325_Gln2326del | conservative_inframe_deletion | 47/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6973_6978delCAGCAG | p.Gln2325_Gln2326del | conservative_inframe_deletion | 47/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6937_6942delCAGCAG | p.Gln2313_Gln2314del | conservative_inframe_deletion | 46/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6832_6837delCAGCAG | p.Gln2278_Gln2279del | conservative_inframe_deletion | 46/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389 | c.*56_*61delCAGCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432 | c.*182_*187delCAGCAG | 3_prime_UTR_variant | 48/48 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000635895 | c.*182_*187delCAGCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009 | c.*182_*187delCAGCAG | 3_prime_UTR_variant | 47/47 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276 | c.*182_*187delCAGCAG | 3_prime_UTR_variant | 46/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 57375AN: 147566Hom.: 12009 Cov.: 0 FAILED QC
GnomAD3 genomes
AF:
AC:
57375
AN:
147566
Hom.:
Cov.:
0
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.245 AC: 12734AN: 52038Hom.: 2290 AF XY: 0.251 AC XY: 7506AN XY: 29882
GnomAD3 exomes
AF:
AC:
12734
AN:
52038
Hom.:
AF XY:
AC XY:
7506
AN XY:
29882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.308 AC: 387948AN: 1259014Hom.: 36422 AF XY: 0.309 AC XY: 191427AN XY: 619668
GnomAD4 exome
AF:
AC:
387948
AN:
1259014
Hom.:
AF XY:
AC XY:
191427
AN XY:
619668
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.389 AC: 57414AN: 147668Hom.: 12013 Cov.: 0 AF XY: 0.383 AC XY: 27560AN XY: 71882
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
57414
AN:
147668
Hom.:
Cov.:
0
AF XY:
AC XY:
27560
AN XY:
71882
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 20, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2020 | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 40% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 37. Only high quality variants are reported. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Spinocerebellar ataxia type 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Episodic ataxia type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Migraine, familial hemiplegic, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Developmental and epileptic encephalopathy, 42 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at